PillRx only · Kit
Glucagon
7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
7 active makers
7 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$179.179
Latest avg · Jul 22, 2026
-19%
Since Dec 17, 2025
7
Active US suppliers
50%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
24K
Rx · 2026 Q1
30K
Units dispensed
-16%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it7 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi USA, LLC | unknown | 3 | SUPPLYING |
| Sportpharm LLC | unknown | 2 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 1 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
| Cipla USA Inc. | unknown | 1 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| Amphastar Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 23, 2026RECALLRecall (Not Yet Classified): Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syring…
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the U.S.